Prevalence, Incidence, Prognosis, and Predisposing Conditions for Atrial Fibrillation: Population-Based Estimates

American Journal of Cardiology

Volumn 82, Issue 7 A, 1998, Pages 2N-9N

  Kannel, W B ^a   Wolf, P A ^a   Benjamin, E J ^a   Levy, D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CARDIOVASCULAR RISK; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE PREDISPOSITION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STROKE; VALVULAR HEART DISEASE;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; CAUSALITY; CEREBROVASCULAR DISORDERS; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MALE; MASSACHUSETTS; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 0346613575     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Kannel WB, Abbott RD, Savage DD, McNamara PM. Coronary heart disease and atrial fibrillation: The Framingham Study. Am Heart J 1983;106:389-396.
2. Aberg H. Atrial fibrillation: a review of 463 cases from Philadelphia General Hospital from 1955 to 1965. Acta Med Scand 1968;184:425-431.
3. Sawyer CG, Bolin LB, Stevens EL, Daniel LB, ONeil NC, Hayes DM. Atrial fibrillation: its etiology, treatment and association with embolization. South Med J 1958;51:84-93.
4. Onundarson PT, Thorgeirsson G, Jonmundsson E, Sigfusson N, Hardarson T. Chronic atrial fibrillation - epidemiologic features and 14-year follow-up: a case control study. Eur Heart J 1987;8:521-527.
5. Lake FR, Cullen KJ, deKlerk NH, McCall MG, Rosman DL. Atrial fibrillation and mortality in an elderly population. Aust NZ J Med 1989;19:321-326.
6. Shurtleff D. Some characteristics related to the incidence of cardiovascular disease and death: Framingham Study, 18-year follow-up. In: Kannel WB, Gordon T, eds. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Washington DC: Dept of Health Education and Welfare; 1974;Section 30. DHEW publication NIH 74-599.
7. Benjamin EJ, Levy D, Vaziri SM, DAgostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994;271:840-844.
8. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution and gender in patients with atrial fibrillation; analysis and implications. Arch Intern Med 1995;155:469-473.
9. Wolf PA, Benjamin EJ, Belanger AJ, Kannel WB, Levy D, D'Agostino RB. Secular trends in the prevalence of atrial fibrillation: The Framingham Study. Am Heart J 1996;131:790-795.
10. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Study. Circulation 1994;89: 724-730.
11. Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study. Neurology 1978;28;973-977.
12. Britton M, Gustafson C. Non-rheumatic atrial fibrillation as a risk factor for stroke. Stroke 1985;16:182-188.
13. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: The Framingham Study. N Engl J Med 1982;306: 1018-1022.
14. Gajewski J, Singer RB. Mortality in an insured population with atrial fibrillation. JAMA 1981;245:1540-1544.
15. Cardiogenic brain embolism: the second report of the Cerebral Embolism Task Force. Arch Neurol 1989;46:727-743.
16. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly: The Framingham Study. Arch Intern Med 1987;147:1561-1564.
17. Britton M, Gustafsson C. Non-rheumatic atrial fibrillation as a risk factor for stroke. Stroke 1985;16:182-188.
18. Friedman GD, Loveland DB, Ehrlich SP Jr. Relationship of stroke to other cardiovascular disease. Circulation 1968;38:533-541.
19. Peterson P, Godtfredson J. Embolic complications in paroxysmal atrial fibrillation. Stroke 1986;17:622-626.
20. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983-988.
21. Sherman DG, Goldman L, Whiting RB, Jurgensen K, Kaste M, Easton JD. Thromboembolism in patients with atrial fibrillation. Arch Neurol 1984;41:708-710.
22. Wolf PA, Kannel WB, McGee DL, Meeks SL, Bharucha NE, McNamara PM. Duration of atrial fibrillation and imminence of stroke: The Framingham Study. Stroke 1983;14:664-667.
23. Corbalan R, Arriagada D, Braun S, Tapia J, Huete I, Kramer A, Chaves A. Risk factors for systemic embolization in patients with paroxysmal atrial fibrillation. Am Heart J 1992;124:149-153.
24. Vingerhoets F, Bogousslavsky J, Regli F, Van Melle G. Atrial fibrillation after acute stroke. Stroke 1993;24:26-30.
25. Lin H-J, Wolf PA, Benjamin EJ, Belanger AJ, D'Agostino RB. Newly diagnosed atrial fibrillation and acute stroke. The Framingham Study. Stroke 1995;26:1527-1530.
26. Flegel KM, Hanley J. Risk factors for stroke and other embolic events in patients with nonrheumatic atrial fibrillation. Stroke 1989;20:1000-1004.
27. Lin H-J, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, D'Agostino RB. Stroke severity in atrial fibrillation: The Framingham Study. Stroke 1996;27:1760-1764.
28. Matsuda Y, Toma Y, Moritani K, Ogawa H, Kohno M, Miura T, Matsuda M, Matsuzaki M, Fujii H, Kusukawa R. Assessment of left atrial function in patients with hypertensive heart disease. Hypertension 1986;8:779-785.
29. Smith VE, White WB, Karimeddini MK. Echocardiographic assessment left ventricular diastolic performance in hypertensive subjects: correlation with changes in left ventricular mass. Hypertension 1987;9(suppl II):II-81-II-84.
30. Crenshaw BS, Ward SR, Granger CB, Stebbens AL, Topol EJ, Califf RM. For the GUSTO-I Trial Investigators. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol 1997;30: 406-413.
31. Sakata K, Kurihara H, Iwamori K, Maki A, Yoshino H, Yanagisawa A, Ishikawa K. Clinical and prognostic significance of atrial fibrillation in acute myocardial infarction. Am J Cardiol 1997;80:1522-1527.
32. Goldberg RJ, Seeley D, Becker RC, Brady P, Chen ZY, Osganian V, Gore JM, Alpert JS, Dalen JE. Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: a community-wide perspective. Am Heart J 1990;119:996-1001.
33. Behar S, Tanne D, Zion M, Reicher-Reiss H, Kaplinsky E, Caspi A, Palant A, Goldbourt U, for the SPRINT Study Group. Incidence and prognostic significance of chronic atrial fibrillation among 5,839 consecutive patients with acute myocardial infarction. Am J Cardiol 1992;70:816-818.
34. Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure: a study of 390 patients. Circulation 1991;84:40-48.
35. Jorgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS. Acute stroke with atrial fibrillation: the Copenhagen Stroke Study. Stroke 1996;27:1765-1769.
36. Carson PE, Johnson GR, Dunkman WB, Fletcher RD. Farrell L, Cohen JN. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation 1993;87:VI-102-VI-110.
37. Keogh AM, Baron DW, Hickie JB. Prognostic guides in patients with idiopathic or dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol 1990;65:903-908.
38. Censori B, Camerlingo M, Casto L, Ferraro B, Gazzaniga GC, Cesana B, Mamoli A. Prognostic factors in first ever stroke in the carotid artery territory seen within 6 hours after onset. Stroke 1993;24:532-535.
39. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors and prognosis in the Manitoba Follow-up Study. Am J Med 1995;98:476-484.
40. Flegel KM, Shipley MJ, Rose G. Risk of stroke in non-rheumatic atrial fibrillation. Lancet 1987;i:526-529.
41. Kulbertus HE, Leval-Rutten F, Bartch P, Petit JM. Atrial fibrillation in elderly ambulatory patients. In: Kulbetus HE, Olssen SB, Schlepper M, eds. Atrial Fibrillation. Molndal, Sweden: AB Hassle, 1982:148-157.
42. Kitchin AH, Milne JS. Longitudinal survey of ischaemic heart disease in randomly selected sample of older population. Br Heart J 1977;39:889-893.
43. Petersen P, Godtfredsen J, Boysen G, Andersen ED, Andersen B. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK Study. Lancet 1989;i:175-179.
44. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N Engl J Med 1990;323:1505-1511.
45. Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study: final results. Circulation 1991;84;527-539.
46. Ezekowitz MD, Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, Krause-Steinrauf H, Kurtzke JF, Nazarian SM, Radford MJ, et al, for the Veterans Affairs Stroke Prevention in Non-rheumatic Atrial Fibrillation Investigators. Warfarin in the prevention of stroke associated with non-rheumatic atrial fibrillation. N Engl J Med 1992;327:1406-1412.